🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to evaluate the efficacy, safety and tolerability...
Status
Not Yet Recruiting
Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Start Date
2025-08-01
Trial ID
NCT07093931
Treatments Being Tested
The purpose of this single arm, phase Ⅱ clinical trail is to determine the ...
Status
Unknown
Location
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Start Date
2019-02-15
Trial ID
NCT03830385
Treatments Being Tested
This study aims to systematically evaluate the safety and efficacy of adali...
Status
Recruiting
Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Start Date
2026-05-22
Trial ID
NCT07595770
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
This is a phase II study to assess the efficacy, safety, and Health Related...
Status
Recruiting
Location
Ryan Nguyen
Start Date
2022-12-28
Trial ID
NCT05613413
Treatments Being Tested
The primary scientific question of interest of this study is whether the co...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT05809895
Treatments Being Tested
Evaluate the efficacy and safety of neoadjuvant chemotherapy (NAC) with alb...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2022-03-14
Trial ID
NCT05367206
Treatments Being Tested
Non-resectable stage III non-small cell lung cancer is recommended for conc...
Status
Unknown
Location
Affiliated Hospital of Guizhou Medical University
Start Date
2019-09-01
Trial ID
NCT04284215
Treatments Being Tested
This phase Ib trials studies the side effects and how well talimogene laher...
Status
Completed
Location
University of California, San Francisco
Start Date
2020-02-05
Trial ID
NCT03554044
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914